Position in BCRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$250,000
+$12,000 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#188
of 316 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $250,000 across 1 Drug Manufacturers - Specialty & Generic name. BCRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
25,000 | $250,000 |
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,000 | 25,000 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $238,000 | 25,000 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $195,000 | 25,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $189,750 | 25,000 | Shares | Sole | 2025-10-28 | |
| No filing history on record for this holder in this stock. | ||||||